Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The utility of BRAF testing in the management of papillary thyroid cancer.

The oncologist - 1 Jan 2010

Melck Adrienne L, Yip Linwah, Carty Sally E

Abstract excerpt

Over the last decade, investigators have developed a clearer understanding of the genetic alterations underlying thyroid carcinogenesis. A number of biomarkers involved in the pathogenesis of differentiated thyroid cancer have undergone intensive study, not only for their role in tumorigenesis, but also for their potential utility as diagnostic and prognostic indicators and therapeutic targets. This review...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Papillary
Share to BRAF gene
Share to Mutation

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Prognosis

Share to Proto-Oncogene Proteins B-raf

Share to Thyroid Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 21147872
DOI: 10.1634/theoncologist.2010-0156
PMCID: PMC3227917

Genes

BRAF

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The utility of BRAF testing in the management of papillary thyroid cancer.PMID 21147872Read ↗

BRAF(V⁶⁰⁰E) mutation and its association with clinicopathological features of papillary thyroid microcarcinoma: A meta-analysis.Semantic proximity Read ↗

BRAF mutation in papillary thyroid carcinoma: pathogenic role and clinical implications.Semantic proximity Read ↗

BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis.Semantic proximity Read ↗

Update on Molecular Diagnostics in Thyroid Pathology: A ReviewSemantic proximity Read ↗

Clinical impact of the detection of BRAF mutations in thyroid pathology: potential usefulness as diagnostic, prognostic and theragnostic applications.Semantic proximity Read ↗

Prognostic utility of BRAF mutation in papillary thyroid cancer.Semantic proximity Read ↗

BRAF Mutation Predicts a Poorer Clinical Prognosis for Papillary Thyroid CancerSemantic proximity Read ↗

Association of BRAFV600E Mutation with the Aggressive Behavior of Papillary Thyroid Microcarcinoma: A Meta-Analysis of 33 Studies.Semantic proximity Read ↗

Molecular evaluation of BRAF gene mutation in thyroid tumors: Significant association with papillary tumors and extra thyroidal extension indicating its role as a biomarker of aggressive diseaseSemantic proximity Read ↗

The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma.Semantic proximity Read ↗

Comparative BRAF V600E immunohistochemical expression in differentiated thyroid tumors with papillary features.Semantic proximity Read ↗

BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.